Dow Down 0.05% Nasdaq Up 0.37%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.60 Down 0.01(1.77%) 12:27PM EST - Nasdaq Real Time Price
Prev Close:0.61
Open:0.61
Bid:0.60 x 300
Ask:0.60 x 300
1y Target Est:3.50
Beta:1.78
Next Earnings Date:N/A
Day's Range:0.57 - 0.60
52wk Range:0.53 - 3.52
Volume:345,159
Avg Vol (3m):386,166
Market Cap:37.63M
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCDown 1.77%37.63M
AGENUp 1.35%188.05M
DNDNDown 13.61%19.69M
STMLUp 1.39%189.33M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.17
Quarterly EPS Est (Dec-14) :-0.05
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback